Home  /  The AO Blog  /  Aesthetics

Prejuvenation: the word the industry invented, and what is behind it.

A marketing term with a real clinical idea buried inside it. Worth separating the two before you spend a decade paying for the wrong one.

Written by Dr. Kamen Ng. Medically reviewed 2026-07-28. Last reviewed 2026-07-28. 8 min read

Where the word came from

Prejuvenation is a marketing word, not a clinical one. It has no agreed definition and no diagnostic threshold. Underneath it, though, sits a real and defensible idea: collagen production declines from around the mid-thirties, and preventing loss is easier and cheaper than restoring it later. The problem is that a sound principle is being used to sell maintenance protocols to people who do not yet need them.

Prejuvenation is not a term from a textbook. It arrived from marketing, sometime in the last decade or so, as a way of selling treatment to people who did not yet have a complaint.

That origin is worth holding on to, because it tells you what the word is for. It exists to convert a healthy young face into a customer.

None of which means the underlying idea is wrong. It means the word is doing work that the evidence has not fully earned, and it is worth separating the two.

The part that is defensible

Collagen production starts declining gradually from the mid-twenties. For most people the visible consequences arrive from the mid-thirties, and in women it accelerates around menopause. Elastin, which allows skin to spring back, does not regenerate meaningfully in adults at all.

Two things follow, and both are genuinely useful.

The first is that protecting what you have is cheaper and more effective than rebuilding it. Sun protection is the single largest modifiable factor here, and it is not a close contest. Photoaging degrades collagen and elastin directly, and in this climate the exposure is daily and incidental rather than occasional.

The second is more specific. A line etches into skin because the same fold is repeated tens of thousands of times while the skin's capacity to recover declines. Reduce how hard that fold happens before the line sets, and the etching happens more slowly or not at all. That is a real preventative mechanism, and it is the one legitimate clinical idea inside the marketing word.

The part that is not

A twenty-two-year-old on a quarterly maintenance protocol is not being prevented from anything. She has full collagen density, complete elastic recoil, and no lines visible at rest. There is nothing there to prevent yet.

What she is being sold is a decade of maintenance ahead of the point where it would have started doing anything.

I want to be careful here, because there is a lot of frightening and unsupported material circulating about this. Early treatment does not accelerate ageing. It does not cause dependence, and stopping does not produce a rebound. Those claims are not supported and I am not making them.

My objection is simpler. It is money spent on the wrong thing, at an age when the right thing is dramatically cheaper.

What genuinely counts as preventative

Three things, in order of how much they matter.

Sun protection, daily, for life. Nothing else in aesthetic medicine comes close on return for money spent, and in Fitzpatrick IV and V skin it needs to cover visible light as well as ultraviolet. My colleague Dr. Farah writes about that in detail.

Skin quality. Hydration, dermal thickness and barrier function are the substrate everything else sits on. This is where a patient in her twenties who wants to do something useful should be spending, and much of it is topical rather than procedural.

Treating a specific fold that is beginning to set. Not a face, not a schedule. A particular line, visible at rest, that was not there two years ago, in a person whose expression habits are clearly driving it. That is the narrow case where injectable prevention genuinely applies.

Notice that the third one is the only injectable on the list, and it has a threshold attached to it.

What it costs to get this wrong

Three sessions a year for ten years is thirty sessions.

If those ten years began when the patient genuinely had lines setting at rest, that spending bought something real. If they began at twenty-two because a word in an advertisement suggested it should, a considerable proportion of it prevented nothing measurable. Our prices are published openly, so you can do that arithmetic yourself before you commit to anything.

There is a second cost. Patients who begin very young often lose track of their own baseline, and that makes every subsequent decision harder to judge, both for them and for me.

The question to ask any clinic

Ask what specifically they are preventing in your face.

A good answer is concrete. It names a line, describes the movement creating it, and explains what would happen over the next several years if it were left alone. A weak answer talks about prejuvenation, about starting early, or about what other patients your age are doing.

If nobody can name what is being prevented, nothing is.

What I tell patients in their twenties

Usually that they do not need me yet, which is not what most of them came to hear.

Wear sunscreen every day, including the days you will be indoors, because in this climate you will not be indoors as much as you think. Look after your skin quality. Come back when you can see something at rest that was not there before, and if that is five years away, that is a good outcome rather than a delay.

Some are relieved. Some book elsewhere and are treated within the week, which I cannot control and do not judge them for.

But I would rather send someone away with a recommendation for a sunscreen than begin a decade of treatment for a face that had not yet asked for it.

Frequently asked questions

Prejuvenation is an industry term for aesthetic treatment intended to prevent visible ageing rather than correct it. It is a marketing coinage rather than a clinical category, with no agreed definition or threshold. The idea beneath it is legitimate: collagen declines from the mid-thirties, and slowing loss is easier than reversing it. The term itself tells you nothing about whether you need anything.

Collagen production begins declining gradually from the mid-twenties and the loss becomes visible for most people from the mid-thirties onward, accelerating around menopause in women. Sun exposure accelerates it substantially, which is why two people of the same age can differ markedly.

The preventative principle is sound for treatments that reduce repeated skin folding before a line sets, and for measures that protect collagen. It is not supported for treating faces with no signs of change, where there is nothing to prevent yet. The evidence supports preventing a specific process, not preventing ageing in general.

Usually not, in the injectable sense. At twenty-five most patients have no lines visible at rest, so there is nothing to prevent. The genuinely valuable preventative work at that age is daily sun protection and skin quality, and it costs a fraction of a treatment programme.

Daily broad-spectrum sun protection, including against visible light in darker skin. Measures that support skin quality and dermal thickness. And, where a fold is genuinely beginning to set at rest, conservative treatment of that specific movement. Not a package, and not a schedule set by age.

Three sessions a year over ten years is thirty sessions. For a patient who began in their early twenties, before anything was visible at rest, a considerable proportion of those sessions were not preventing anything measurable. Our prices are published openly so you can work out what that means before committing.

This article is general educational information about aesthetic medical procedures. It is not medical advice, a diagnosis, or an offer of treatment. Botulinum toxin is a prescription medicine registered in Malaysia by the National Pharmaceutical Regulatory Agency; injectable fillers and bio-stimulators are devices registered with the Medical Device Authority. All are supplied and administered only by registered medical practitioners. Suitability, technique and outcomes vary between individuals and no result can be guaranteed.

KN
Dr. Kamen NgHead of Aesthetic Medicine, AOKLINIK

Merz Masterclass trained. Thirteen years treating Malaysian skin, specialising in personalised hybrid protocols with established bio-stimulators and fillers. Meet the team.

Book an assessment Aesthetic Medicine Glossary of terms
Book Your Consultation
Find Your TreatmentBook Now